Review Article| Volume 15, ISSUE 2, P187-195, April 2020

18F-Fluorodeoxyglucose PET/Computed Tomography in Endocarditis

Published:January 28, 2020DOI:


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to PET Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Millar B.C.
        • de Camargo R.A.
        • Alavi A.
        • et al.
        PET/Computed tomography evaluation of infection of the heart.
        PET Clin. 2019; 14: 251-269
        • Osborne M.T.
        • Hulten E.A.
        • Murthy V.L.
        • et al.
        Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation.
        J Nucl Cardiol. 2017; 24: 86-99
        • Larson S.R.
        • Pieper J.A.
        • Hulten E.A.
        • et al.
        Characterization of a highly effective preparation for suppression of myocardial glucose utilization.
        J Nucl Cardiol. 2019; ([Epub ahead of print])
        • Christopoulos G.
        • Jouni H.
        • Acharya G.A.
        • et al.
        Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: the effect of a structured patient preparation protocol.
        J Nucl Cardiol. 2019; ([Epub ahead of print])
        • Kumita S.
        • Yoshinaga K.
        • Miyagawa M.
        • et al.
        Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations.
        J Nucl Cardiol. 2019; 26: 1414-1433
        • Scholtens A.M.
        • Verberne H.J.
        • Budde R.P.
        • et al.
        Additional heparin preadministration improves cardiac glucose metabolism suppression over low-carbohydrate diet alone in (18)F-FDG PET imaging.
        J Nucl Med. 2016; 57: 568-573
        • Saby L.
        • Laas O.
        • Habib G.
        • et al.
        Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion.
        J Am Coll Cardiol. 2013; 61: 2374-2382
        • Mahmood M.
        • Kendi A.T.
        • Ajmal S.
        • et al.
        Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis.
        J Nucl Cardiol. 2017; 26: 922-935
        • Swart L.E.
        • Gomes A.
        • Scholtens A.M.
        • et al.
        Improving the diagnostic performance of (18)F-fluorodeoxyglucose positron-emission tomography/computed tomography in prosthetic heart valve endocarditis.
        Circulation. 2018; 138: 1412-1427
        • de Camargo R.A.
        • Bitencourt M.S.
        • Meneghetti J.C.
        • et al.
        The role of 18F-FDG-PET/CT in the Diagnosis of left-sided Endocarditis: native vs. prosthetic valves endocarditis.
        Clin Infect Dis. 2019; ([pii:ciz267] [Epub ahead of print])
        • Kouijzer I.J.E.
        • Berrevoets M.A.H.
        • Aarntzen E.H.J.G.
        • et al.
        18F-fluorodeoxyglucose positron-emission tomography combined with computed tomography as a diagnostic tool in native valve endocarditis.
        Nucl Med Commun. 2018; 39: 747-752
        • Mahmood M.
        • Kendi A.T.
        • Farid S.
        • et al.
        Role of (18)F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: a meta-analysis.
        J Nucl Cardiol. 2019; 26: 958-970
        • Diemberger I.
        • Bonfiglioli R.
        • Martignani C.
        • et al.
        Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study.
        Eur J Nucl Med Mol Imaging. 2019; 46: 194-205
        • Tam M.C.
        • Patel V.N.
        • Weinberg R.L.
        • et al.
        Diagnostic accuracy of FDG PET/CT in suspected LVAD infections: a case series, systematic review, and meta-analysis.
        JACC Cardiovasc Imaging. 2019; ([pii:S1936-878X(19)30568-6]. [Epub ahead of print])
        • de Vaugelade C.
        • Mesguich C.
        • Nubret K.
        • et al.
        Infections in patients using ventricular-assist devices: comparison of the diagnostic performance of (18)F-FDG PET/CT scan and leucocyte-labeled scintigraphy.
        J Nucl Cardiol. 2019; 26: 42-55
        • Elefteriades J.A.
        • Botta Jr., D.M.
        Avoiding technical pitfalls in left ventricular assist device placement.
        Cardiol Clin. 2011; 29: 507-514
        • Pizzi M.N.
        • Roque A.
        • Fernandez-Hidalgo N.
        • et al.
        Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-Fluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center.
        Circulation. 2015; 132: 1113-1126
        • Gomes A.
        • van Geel P.P.
        • Santing M.
        • et al.
        Imaging infective endocarditis: adherence to a diagnostic flowchart and direct comparison of imaging techniques.
        J Nucl Cardiol. 2018; ([Epub ahead of print])
        • Hyafil F.
        • Rouzet F.
        • Le Guludec D.
        Nuclear imaging for patients with a suspicion of infective endocarditis: Be part of the team!.
        J Nucl Cardiol. 2017; 24: 207-211
        • Caldarella C.
        • Leccisotti L.
        • Treglia G.
        • et al.
        Which is the optimal acquisition time for FDG PET/CT imaging in patients with infective endocarditis?.
        J Nucl Cardiol. 2013; 20: 307-309
        • Leccisotti L.
        • Perna F.
        • Lago M.
        • et al.
        Cardiovascular implantable electronic device infection: delayed vs standard FDG PET-CT imaging.
        J Nucl Cardiol. 2014; 21: 622-632
        • Scholtens A.M.
        • Swart L.E.
        • Verberne H.J.
        • et al.
        Dual-time-point FDG PET/CT imaging in prosthetic heart valve endocarditis.
        J Nucl Cardiol. 2018; 25: 1960-1967
        • Habib G.
        • Lancellotti P.
        • Antunes M.J.
        • et al.
        • Authors/Task Force Members
        2015 ESC guidelines for the management of infective endocarditis: the task Force for the management of infective endocarditis of the European Society of Cardiology (ESC)endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).
        Eur Heart J. 2015; 36: 3075-3128
        • Mathieu C.
        • Mikail N.
        • Benali K.
        • et al.
        Characterization of 18F-fluorodeoxyglucose uptake pattern in noninfected prosthetic heart valves.
        Circ Cardiovasc Imaging. 2017; 10: e005585
        • Scholtens A.M.
        • Budde R.P.J.
        • Lam M.G.E.H.
        • et al.
        FDG PET/CT in prosthetic heart valve endocarditis: there is no need to wait.
        J Nucl Cardiol. 2017; 24: 1540-1541
        • Scholtens A.M.
        • Swart L.E.
        • Kolste H.J.T.
        • et al.
        Standardized uptake values in FDG PET/CT for prosthetic heart valve endocarditis: a call for standardization.
        J Nucl Cardiol. 2017; 25: 2084-2091